Related references
Note: Only part of the references are listed.Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension
Yeong Hann Ling et al.
PHARMACOLOGICAL RESEARCH (2017)
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Ian H. de Boer et al.
DIABETES CARE (2017)
Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice
S. M. Krishnan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage
Thiago Bruder-Nascimento et al.
CIRCULATION (2016)
Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus
Marcondes Alves B. Silva et al.
CLINICAL SCIENCE (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation
Nathanne S. Ferreira et al.
FRONTIERS IN PHARMACOLOGY (2015)
Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling
Marcondes A. B. Silva et al.
FRONTIERS IN PHYSIOLOGY (2015)
The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
Susana Vallejo et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Spironolactone Decreases DOCA-Salt-Induced Organ Damage by Blocking the Activation of T Helper 17 and the Downregulation of Regulatory T Lymphocytes
Cristian A. Amador et al.
HYPERTENSION (2014)
Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats
Toshiki Doi et al.
PLOS ONE (2014)
The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes
Thiago Bruder-Nascimento et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II
Joshua A. Beckman et al.
EUROPEAN HEART JOURNAL (2013)
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Francesco Paneni et al.
EUROPEAN HEART JOURNAL (2013)
Vascular Actions of Aldosterone
Marie Briet et al.
JOURNAL OF VASCULAR RESEARCH (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1
Yoshio Terada et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways Implications in Diabetes Mellitus-Associated Obesity and Vascular Dysfunction
Ana M. Briones et al.
HYPERTENSION (2012)
T Regulatory Lymphocytes Prevent Aldosterone-Induced Vascular Injury
Daniel A. Kasal et al.
HYPERTENSION (2012)
Mitochondria: Sovereign of inflammation?
Juerg Tschopp
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou et al.
NATURE (2011)
Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice
Michael G. Usher et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Aldosterone Promotes Autoimmune Damage by Enhancing Th17-Mediated Immunity
Andres A. Herrada et al.
JOURNAL OF IMMUNOLOGY (2010)
Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure
Amanda J. Rickard et al.
HYPERTENSION (2009)
Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles
K. Swaminathan et al.
DIABETOLOGIA (2008)
Aldosterone and vascular inflammation
Nancy J. Brown
HYPERTENSION (2008)
Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction
Tomasz J. Guzik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Shawna A. Cooper et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Interleukin 1-beta (IL-1β) enhances contractile responses in endothelium-denuded aorta from hypertensive, but not normotensive, rats
Anne M. Dorrance
VASCULAR PHARMACOLOGY (2007)
Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus
Christine Guo et al.
ENDOCRINOLOGY (2006)
COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice
ZH Guo et al.
CARDIOVASCULAR RESEARCH (2005)
Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats:: role of the NFκB/IκB system
D Sanz-Rosa et al.
JOURNAL OF HYPERTENSION (2005)
Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients
J Davies et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells
IZ Jaffe et al.
CIRCULATION RESEARCH (2005)
Plasma aldosterone concentration in the patient with diabetes mellitus
NK Hollenberg et al.
KIDNEY INTERNATIONAL (2004)
Aldosterone in the development and progression of renal injury
NK Hollenberg
KIDNEY INTERNATIONAL (2004)
ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension
GE Callera et al.
HYPERTENSION (2003)
ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension
GE Callera et al.
HYPERTENSION (2003)
Aldosterone-induced inflammation in the rat heart - Role of oxidative stress
Y Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Share Paper
